AMFIZA 50 Injection 1's
Netmeds First Membership
Quick Links
INTRODUCTION ABOUT AMFIZA 50 INJECTION
AMFIZA 50 INJECTION contains Amphotericin B which belongs to the group of medicines called Anti-fungal agents. AMFIZA 50 INJECTION is used to manage invasive fungal infections in patients who are resistant/intolerant to conventional Amphotericin B therapy.
AMFIZA 50 INJECTION is not recommended for use in patients allergic to Amphotericin B. It is also not recommended for use in patients with common/superficial, clinically inapparent fungal infections (which are detectable only by positive skin/serologic tests).
Before receiving AMFIZA 50 INJECTION, inform your doctor if you are neutropenic, and/or have liver problems (such as hepatic impairment), and suffer from kidney problems/undergoing dialysis.
AMFIZA 50 INJECTION should be used with caution in pregnant and breast-feeding women only if it is clearly necessary. It is also used with caution in children and adolescents (aged below 18 years) and in elders (aged above 65 years) after consulting with the doctor.
The most common side effects of receiving AMFIZA 50 INJECTION are fever, chills, and/or rigors. Consult your doctor if any of these symptoms worsen.
USES OF AMFIZA 50 INJECTION
- Manage invasive fungal infections in patients who are resistant/intolerant to conventional Amphotericin B therapy
HOW AMFIZA 50 INJECTION WORKS
AMFIZA 50 INJECTION binds to ergosterol (steroid present on the cell membranes of fungi) which leads to the formation of pores and ion leakage on the cell membrane resulting in fungal cell death thus managing invasive fungal infections in affected individuals.
DIRECTIONS FOR USE
AMFIZA 50 INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
SIDE EFFECTS OF AMFIZA 50 INJECTION
COMMON
- fever
- chills/rigors
WARNING & PRECAUTIONS
PREGNANCY
AMFIZA 50 INJECTION should be administered with caution in pregnant women only if it is clearly necessary. Consult your doctor before receiving the medicine.
BREASTFEEDING
AMFIZA 50 INJECTION should be administered with caution in breastfeeding women only if it is clearly necessary. Consult your doctor before receiving the medicine.
DRIVING AND USING MACHINES
AMFIZA 50 INJECTION is unlikely to affect your ability to drive/operate machines. Consult your doctor before receiving AMFIZA 50 INJECTION.
KIDNEY
AMFIZA 50 INJECTION should be administered with caution in patients with kidney disease and in patients who are under dialysis. Consult your doctor before receiving the medicine.
LIVER
AMFIZA 50 INJECTION should be administered with caution in patients with hepatic impairment, and/or other liver disease. Consult your doctor before receiving AMFIZA 50 INJECTION.
ALLERGY
Do not receive AMFIZA 50 INJECTION if you are allergic to Amphotericin B, and/or any other ingredients of this medicine.
OTHERS
AMFIZA 50 INJECTION is not recommended for use if you:
- have common/superficial, clinically inapparent fungal infections (which are detectable only by positive skin/serologic tests)
Before receiving AMFIZA 50 INJECTION, inform your doctor if you:
- suffer from neutropenia (condition marked by low count of neutrophils)
Use in Pediatrics:
AMFIZA 50 INJECTION should be used with caution in children and adolescents (aged below 18 years). Consult your doctor before child receives the medicine.
Use in Geriatrics:
AMFIZA 50 INJECTION should be used with caution in elderly patients (aged above 65 years). Consult your doctor before receiving AMFIZA 50 INJECTION.
INTERACTIONS
A. Drug–Drug interactions:
Before receiving AMFIZA 50 INJECTION, inform your doctor if you are taking any of the following medicine:
- nephrotoxic drugs (medicines that can cause damage to the kidney) Ex. minoglycosides, cisplatin
- zidovudine (used to manage HIV)
- cyclosporin (used to manage transplanted organ rejection)
Overdosage:
AMFIZA 50 INJECTION will be administered to you only by a doctor or a nurse in a hospital, and so it is unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms.
SYNOPSIS
| Drug | : | Amphotericin B |
| Pharmacological Category | : | Anti-fungal agent |
| Therapeutic Indication | : | Invasive fungal infection |
| Dosage Forms | : | Injection, Infusion, Emulsion, Gel |
MORE INFORMATION
- Keep AMFIZA 50 INJECTION out of reach of children
- Store AMFIZA 50 INJECTION under refrigeration at 2°C to 8°C
FAQs ABOUT AMFIZA 50 INJECTION
What is AMFIZA 50 INJECTION used for?
AMFIZA 50 INJECTION is an anti-fungal agent which is used to manage invasive fungal infections in patients who are resistant/intolerant to conventional Amphotericin B therapy.
What are the side effects of AMFIZA 50 INJECTION?
The most common side effects of receiving AMFIZA 50 INJECTION are fever, chills, and/or rigors. Consult your doctor if any of these symptoms worsen.
How AMFIZA 50 INJECTION works:
AMFIZA 50 INJECTION binds to ergosterol (steroid present on the cell membranes of fungi) which leads to the formation of pores and ion leakage on the cell membrane resulting in fungal cell death thus managing invasive fungal infections in affected individuals.
How AMFIZA 50 INJECTION is administered?
AMFIZA 50 INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Can AMFIZA 50 INJECTION be used in pregnant and breast-feeding women?
Yes, AMFIZA 50 INJECTION can be administered but with caution in pregnant and breastfeeding women. Consult your doctor before receiving the medicine.
REFERENCES
1. KD. Tripathi. Anti-Fungal Drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page – 787.
2. Neil RH Stone, Tihana Bicanic, Rahuman Salim and William Hope. Liposomal Amphotericin B (AmBisome®): A review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. March 2017. [Accessed on 12th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856207/
3. Satomi Ueda, Shunichi Miyamoto, Kosuke Kaida, Aki Chizuka, Rie Kojima, Junichiro Takano, Toshie Ogasawara, Ko Miyamoto, Shigesaburo Miyakoshi, Yoshinobu Kanda. Safety and efficacy of treatment with liposomal amphotericin B in elderly patients at least 65 years old with hematological diseases. NIH National Library of Medicine. National Center for Biotechnology Information. PubMed.gov. May 2016. [Accessed on 12th May 2022] https://pubmed.ncbi.nlm.nih.gov/26908230/
4. Bharat Serums and Vaccines Limited. Ampholip. [Accessed on 12th May 2022] https://bsvgroup.com/assets/pdf/products/AMPHOLIP-Common-Pack-Insert-Export-for-Domestic.pdf
USEFUL DIAGNOSTIC TESTS
- Fungal culture test
AUTHOR DETAILS
